[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350941-105":59,"doc-detail-350941-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","hereditary-ovarian-cancer-in-women-with-african-ancestry-a-scoping-review","Hereditary ovarian cancer in women with African ancestry - a scoping review","","This scoping review investigates genetic variants associated with hereditary ovarian cancer in women of African ancestry. Around 20% of ovarian cancers are hereditary, with BRCA1 and BRCA2 variants accounting for 20–55% of cases, while other genes implicated include BRIP1, ATM, RAD51C, RAD51D, and Lynch syndrome genes. Diagnosis is critical for patient management, surveillance, and cascade testing, yet the genetic basis in this population remains limited. Eligible studies required germline testing in affected women; 30 studies met criteria, identifying 75 pathogenic variants across 110 families, with 92% in BRCA1/BRCA2, and only four focused specifically on hereditary ovarian cancer.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hereditary-ovarian-cancer-in-women-with-african-ancestry-a-scoping-review/350941/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hereditary-ovarian-cancer-in-women-with-african-ancestry-a-scoping-review/350941.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What genetic variants are most frequently linked to hereditary ovarian cancer in women of African ancestry?","Question",{"text":113,"@type":114},"Across the included studies, 75 pathogenic variants were found in 110 families, with 92% occurring in BRCA1 or BRCA2.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What criteria determined whether a study was included in the scoping review?",{"text":118,"@type":114},"Studies included women of African ancestry with confirmed primary ovarian, peritoneal, or fallopian tube cancer who underwent germline genetic testing for hereditary cancer syndromes; studies relying only on somatic testing or genome-wide association were excluded.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is accurate diagnosis of hereditary cancer syndromes important?",{"text":122,"@type":114},"It supports patient management and surveillance and enables cascade testing for at-risk relatives, reflecting personal and familial implications.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350941,1790519709,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Familial Cancer (2026) 25:16  \n[https://doi.org/10.1007/s10689-026-00530-x](https://doi.org/10.1007/s10689-026-00530-x)  \nREVIEW  \nHereditary ovarian cancer in women with African ancestry: a scoping review  \nBianca Rossouw1 · Monica Araujo1 · Amanda Krause1 · Fiona Baine-Savanhu1  \nReceived: 6 October 2025 / Accepted: 7 January 2026 © The Author(s) 2026  \nAbstract  \nThis scoping review explored genetic variants associated with hereditary ovarian cancer in women of African ancestry. Around 20% of ovarian cancers are hereditary, with BRCA1 and BRCA2 variants accounting for 20–55% of these cases, while other implicated genes include BRIP1, ATM, RAD51C, RAD51D, and the Lynch syndrome genes. The genetic basis of ovarian cancer in women of African ancestry, however, remains poorly understood. Accurate diagnosis of hereditary cancer syndromes is crucial given their personal and familial implications, informing patient management, surveillance, and cascade testing for at-risk relatives. Eligible studies included women of African ancestry with confirmed primary ovarian, peritoneal, or fallopian tube cancer who underwent germline genetic testing for hereditary cancer syndromes. Studies based solely on somatic testing or genome-wide association approaches were excluded. A comprehensive search of PubMed, Scopus, Web of Science, Google Scholar, and ProQuest Dissertations and Theses Global was conducted. Two reviewers independently screened citations and extracted data using a standardized form, and results were summarised narratively and in tables according to JBI scoping review guidelines. Thirty studies were included, primarily involving African American and North African participants. Only four focused specifically on hereditary ovarian cancer; the remainder primarily examined breast cancer cohorts with some ovarian cancer cases. Across these studies, 75 pathogenic variants were identified in 110 families, with 92% in BRCA1 or BRCA2 . Research on hereditary ovarian cancer in women with African ancestry remains extremely limited, highlighting the urgent need for broader next-generation sequencing studies to inform clinical care.  \nKeywords African population · Germline variants · Hereditary cancer syndromes · Oncology · Ovarian cancer  \nIntroduction  \nOvarian cancer refers broadly to cancers that begin in the cells of the ovary, fallopian tubes, or peritoneum (the serous membrane that covers the uterus, bladder, rectum, ovaries,  \n􀀍 Bianca Rossouw [bianca.rossouw@wits.ac.za](bianca.rossouw@wits.ac.za)  \nMonica Araujo  \n[monica.araujo@wits.ac.za](monica.araujo@wits.ac.za)  \nAmanda Krause  \n[amanda.krause@wits.ac.za](amanda.krause@wits.ac.za)  \nFiona Baine-Savanhu  \n[fiona.baine-savanhu@wits.ac.za](fiona.baine-savanhu@wits.ac.za)  \n1 Division of Human Genetics, National Health Laboratory Service and Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa  \nand fallopian tubes) [1] . An earlier diagnosis has a better prognosis, but globally less than 20% of women with ovarian cancer are diagnosed with early-stage disease [2] . Clinical symptoms of early disease are usually non-specific, and patients are often diagnosed when the cancer is at an advanced stage [1]. As a result, ovarian cancer is associated with a poor prognosis and survival rate. In South Africa, the 5-year survival rate amongst women with advanced-stage ovarian cancer is only 15–20% despite aggressive treatment [3] . According to the South African National Cancer Registry (SANCR), the number of newly reported cases of ovarian cancer in 2016 was 661, of which 225 (34%) were in African females [4] . Based on available data, the International Agency for Research on Cancer (IARC) predicts that by 2040 the number of cases of ovarian cancer in Africa, driven by expected population growth, will increase by 87%, more than anywhere else in the world [5] .  \n1 3  \nOver 20% of patients with European ancestry and ovarian cancer will h","cbCail1wxdh4ph2S","https://ap.wps.com/l/cbCail1wxdh4ph2S","pdf",1554893,11,"English","# Abstract\n# Introduction","[{\"question\":\"What genetic variants are most frequently linked to hereditary ovarian cancer in women of African ancestry?\",\"answer\":\"Across the included studies, 75 pathogenic variants were found in 110 families, with 92% occurring in BRCA1 or BRCA2.\"},{\"question\":\"What criteria determined whether a study was included in the scoping review?\",\"answer\":\"Studies included women of African ancestry with confirmed primary ovarian, peritoneal, or fallopian tube cancer who underwent germline genetic testing for hereditary cancer syndromes; studies relying only on somatic testing or genome-wide association were excluded.\"},{\"question\":\"Why is accurate diagnosis of hereditary cancer syndromes important?\",\"answer\":\"It supports patient management and surveillance and enables cascade testing for at-risk relatives, reflecting personal and familial implications.\"}]","Hereditary ovarian cancer in women with African ancestry - a scoping review | PDF",1790091921,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57ce9a119f13f295414e9e455b4bff1d.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41173bd85d1236573ba7182ae1386e90.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b021bd36107537968c024c3b2395d92c.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc8352d5af097749b91b7699b96e7841.webp",980,1301]